Lastly, ISG20, which has been studied in hepatocellular carcinoma and lung cancer, may play a role in modulating the type I interferon response and activating immune cells crucial for antitumor immunity in NBL (58, 59). This evidence concerns the gene ISG20 and hepatocellular carcinoma.